John Herbert Growdon, MD

Affiliations: 
Neurology Massachusetts General Hospital, Harvard University, Boston, MA, United States 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=40
Website:
http://www.mgh.harvard.edu/neurology/doctors/doctor.aspx?id=16420
Google:
"John Growdon"
Bio:

http://madrc.mgh.harvard.edu/john-h-growdon-md

http://www.michaeljfox.org/research_MJFFfundingPortfolio_searchableAwardedGrants_bio.cfm?ID=819

Mean distance: 14.64 (cluster 11)
 
SNBCP
Cross-listing: Alzheimer's Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shirvan J, Clement N, Ye R, et al. (2019) Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease. Neurology
Marquié M, Normandin MD, Vanderburg CR, et al. (2015) Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Annals of Neurology
Hyman BT, Growdon JH, Albers MW, et al. (2015) Massachusetts Alzheimer's Disease Research Center: Progress and challenges. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Rieckmann A, Gomperts SN, Johnson KA, et al. (2015) Putamen-midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases. Neuroimage. Clinical. 8: 554-9
Locascio JJ, Eberly S, Liao Z, et al. (2015) Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease Brain. 138: 2659-2671
Marquie M, Locascio JJ, Rentz DM, et al. (2014) Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study. Alzheimer's Research & Therapy. 6: 52
Growdon JH, Hyman BT. (2014) APOE genotype and brain development. Jama Neurology. 71: 7-8
Santiago JA, Scherzer CR, Potashkin JA, et al. (2013) Specific splice variants are associated with Parkinson's disease Movement Disorders. 28: 1724-1727
Gomperts SN, Johnson KA, Growdon J. (2013) Reply: Beyond the limits of detection: failure of PiB imaging to capture true Aβ burden. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 407
Gomperts SN, Locascio JJ, Rentz D, et al. (2013) Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology. 80: 85-91
See more...